Related references
Note: Only part of the references are listed.Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
Moses K. Donkor et al.
IMMUNITY (2011)
Autocrine Transforming Growth Factor-β1 Promotes In Vivo Th17 Cell Differentiation
Ilona Gutcher et al.
IMMUNITY (2011)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Dysfunctional Transforming Growth Factor-β Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model
Hong Pu et al.
CANCER RESEARCH (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
An anti-transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments
Jeong-Seok Nam et al.
CANCER RESEARCH (2008)
TGF-β:: A master of all T cell trades
Ming O. Li et al.
CELL (2008)
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
Gerald Willimsky et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes
Peter A. Savage et al.
SCIENCE (2008)
Specificity in cancer immunotherapy
Andrea Schietinger et al.
SEMINARS IN IMMUNOLOGY (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
The adaptive immune response to sporadic cancer
Gerald Willimsky et al.
IMMUNOLOGICAL REVIEWS (2007)
Ulcerative colitis and autoirnmunity induced by loss of myeloid αv integrins
Adam Lacy-Hulbert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice
Mark A. Travis et al.
NATURE (2007)
T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation
Ming O. Li et al.
IMMUNITY (2007)
Tumor evasion of the immune system by converting CD4+ CD25- T cells into CD4+ CD25+ T regulatory cells:: Role of tumor-derived TGF-β
Victoria C. Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms
Ming O. Li et al.
IMMUNITY (2006)
Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor
Julien C. Marie et al.
IMMUNITY (2006)
Regulatory T cells in immune surveillance and treatment of cancer
T Yamaguchi et al.
SEMINARS IN CANCER BIOLOGY (2006)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
G Willimsky et al.
NATURE (2005)
Adoptive transfer of tumor-reactive transforming growth factor-β-insensitive CD8+ T cells:: Eradication of autologous mouse prostate cancer
Q Zhang et al.
CANCER RESEARCH (2005)
Prognostic significance of transforming growth factor β receptor II in estrogen receptor-negative breast cancer patients
MB Buck et al.
CLINICAL CANCER RESEARCH (2004)
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells
MJ Turk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo
MA Friese et al.
CANCER RESEARCH (2004)
Tumor-derived TGF-β reduces the efficacy of dendritic cell/tumor fusion vaccine
JY Kao et al.
JOURNAL OF IMMUNOLOGY (2003)
Making sense of latent TGFβ activation
JP Annes et al.
JOURNAL OF CELL SCIENCE (2003)
Suppression of lymphoma and epithelial malignancies effected by interferon γ
SEA Street et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
